NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

顯影劑(影像診斷)-全球市場分析及預測模式(COVID-19對市場造成的影響)

Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact)

出版商 GlobalData 商品編碼 979401
出版日期 內容資訊 英文
訂單完成後即時交付
價格
顯影劑(影像診斷)-全球市場分析及預測模式(COVID-19對市場造成的影響) Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact)
出版日期: 2020年11月30日內容資訊: 英文
簡介

本報告詳細探討2020年及以後的COVID-19對造影劑市場的影響。放射線檢查中使用了造影劑,以更清晰地顯示各種醫學狀況和病理。這些代理與電腦斷層掃描(CT),磁共振成像(MRI)和超聲一起使用,以及其他方式。在CT內,對於大多數CT程序,非離子碘化劑比離子碘化劑更可取。鋇劑通常用於胃腸道成像。MRI造影劑可用於多種程序,而超音波顯影劑目前主要用於超聲心動圖。

本報告提供顯影劑市場相關調查,提供市場概要,以及2015∼2030年的市場預測,各市場區隔,各國的趨勢等資訊。

  • 主要的產業趨勢洞察
  • 2015年∼2030年各分類市場預測
  • 手術數量,台數,平均銷售價格,各分類市場價值相關詳細資料

全球地區,各國趨勢

  • 各國分析
  • SWOT分析
  • 競爭趨勢

健康護理系統概要

  • 醫療保健制度的各國概要
  • 各國給付方針
  • 國家固有的醫療技術相關法規趨勢

網羅的企業-BayerAG,GE 醫療保健 LLC,Guerbet SA,Bracco Imaging SpA,Lantheus Medical Imaging,其他

觀察對象國家:美國,英國,德國,法國,義大利,西班牙,巴西,中國,印度,俄羅斯,日本,澳洲,加拿大,墨西哥,韓國,丹麥,愛爾蘭,荷蘭,紐西蘭,南非,瑞典,瑞士,奧地利,比利時,芬蘭,以色列,挪威,波蘭葡萄牙,台灣,捷克,希臘,匈牙利,土耳其,埃及,沙烏地阿拉伯,阿拉伯聯合大公國,阿根廷,智利

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME699MM

Contrast Agents (Diagnostic Imaging) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.

The model discusses in detail the impact of COVID-19 on Contrast Agents market for the year 2020 and beyond. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computated tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among other modalities. Within CT, non-ionic iodinated agents are preferred over ionic iodinated agents for most CT procedures. Barium-based agents are generally used for imaging the GI tract. MRI contrast agents can be used for a variety of procedures, while ultrasound contrast agents are currently mainly used for echocardiograms.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Contrast Agents and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Contrast Agents market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Contrast Agents market.
  • Competitive dynamics insights and trends provided for Contrast Agents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Bayer AG, GE Healthcare LLC, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Contrast Agents marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Contrast Agents market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Contrast Agents market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Agents market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Contrast Agents market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.